Low prasugrel vs high clopidogrel dose in patients aged greater than or equal to 75 years with ACS and high on clopidogrel platelet reactivity post PCI

Trial Profile

Low prasugrel vs high clopidogrel dose in patients aged greater than or equal to 75 years with ACS and high on clopidogrel platelet reactivity post PCI

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Sep 2012

At a glance

  • Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
  • Indications Acute coronary syndromes; Cardiovascular disorders; Embolism and thrombosis; Stroke
  • Focus Pharmacodynamics
  • Most Recent Events

    • 11 Sep 2012 New trial record
    • 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top